The firm shows a Beta (market volatility) of 0.2419, which signifies not very significant fluctuations relative to the market. Let's try to break down what Axcella's beta means in this case. As returns on the market increase, Axcella Health returns are expected to increase less than the market. However, during the bear market, the loss on holding Axcella Health will be expected to be smaller as well. Even though it is essential to pay attention to
Axcella Health historical returns, it is always good to be careful when utilizing equity current trending patterns. Our philosophy in foreseeing any stock's
future performance is to check both, its past performance charts as well as the business as a whole, including all available
technical indicators. Axcella Health exposes twenty-eight different technical indicators, which can help you to evaluate its performance.
Axcella Health has an expected return of -0.0608%. Please be advised to confirm Axcella Health
sortino ratio,
semi variance, and the
relationship between the
information ratio and
value at risk to decide if
Axcella Health stock performance from the past will be repeated at some point in the near future.
Typically, a company's
financial statements are the reports that show the
financial position of the company. There are three main documents that fall into the category of financial statements. These documents include Axcella Health income statement, its balance sheet, and the statement of cash flows. Potential Axcella Health investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Axcella Health investors may use each financial statement separately, they are all related. The changes in Axcella Health's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Axcella Health's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our
technical analysis and
fundamental analysis pages.
The goal of Axcella Health
fundamental analysis is to do accurate financial forecasts. There are several possible objectives to fundamental analysis, such as projecting of Axcella Health performance into the future periods or doing a reasonable stock valuation. The intrinsic value of Axcella Health shares is the value that is considered the true value of the share. If
the intrinsic value of Axcella is higher than its market price, buying is generally recommended. If it is equal to the market price, it is recommended to hold; and if it is less than the market price, then one should sell all shares Axcella Health. Please read more on our
fundamental analysis page.
How important is Axcella Health's Liquidity
Axcella Health
financial leverage refers to using borrowed capital as a funding source to finance Axcella Health ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Axcella Health financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Axcella Health's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Axcella Health's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the
breakdown between Axcella Health's total debt and its cash.
An Additional Perspective On Axcella Health
Although in the United States, the Securities and Exchange Commission has enforced strong rules to prevent insiders from engaging in insider trading, finding insiders among active shareholders of Axcella Health is not uncomon. There are few distinct groups of Axcella Health stakehholders that the SEC considers insiders. Investors usually gain information through their work as corporate directors, officers, or employees. If these individuals share the information with a friend, family, or business partner and the person who receives the information exchanges stock in the company, he or shie is also an insider. Let's take a look at how the ownership of Axcella is distributed among investors.
Ownership Allocation
Axcella Health holds a total of thirty-six million four hundred fifty thousand
outstanding shares. Over half of Axcella Health outstanding shares are owned by
other corporate entities. These other corporate entities are typically referred to corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these
institutions are subject to different rules and regulation than regular investors in Axcella Health. Please watch out for any change in the
institutional holdings of Axcella Health as this could mean something significant has changed or about to change at the company. Please note that no matter how much assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
| Retail Investors15.22% | Insiders21.71% | Institutions63.07% |
| Retail Investors | 15.22 |
| Insiders | 21.71 |
| Institutions | 63.07 |
Asset Utilization
One of the ways to look at asset utilization of Axcella is to check how much profit was generated for every dollar of assets it reports. Axcella Health shows a negative utilization of assets of -30.36 percent, losing $0.3 for each dollar of assets held by the firm. Unsuccessful asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Axcella Health shows how unproductive it operates for each dollar spent on its assets.
| Current Assets | 91.86 Million | 98.92 |
| Assets Non Current | 1.01 Million | 1.08 |
Are Axcella Health technical ratios showing a come-back?
Current Risk Adjusted Performance is up to -0.07. Price may slip again. Axcella Health exhibits very low volatility with skewness of 0.31 and kurtosis of 0.33. However, we advise investors to further study Axcella Health technical indicators to make sure all market info is available and is reliable.
Our Takeaway on Axcella Health Investment
Whereas other companies in the biotechnology industry are either recovering or due for a correction, Axcella Health may not be performing as strong as the other in terms of long-term growth potentials. The inconsistency in the assessment between current Axcella valuation and our trade advice on Axcella Health is due to the recent market swings and your selection of investing horizon. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Axcella Health.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Gabriel Shpitalnik is a Member of Macroaxis Editorial Board. Gabriel is a young entrepreneur and writes predominantly on the business, technology, and finance sector. He likes to analyze different equity instruments across a wide range of industries focusing primarily on consumer products and evolving technologies.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Gabriel Shpitalnik do not own shares of Axcella Health. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com